Read + Share
Xu Y, Li Y, Pan J, Kang X, et al. EM2D9, a monoclonal antibody against Integrin a5b1, has potent antitumor activity
on endometrial cancer in vitro and in vivo. Cancer Lett 2020 Mar 3. pii: S0304-3835(20)30082.
PMID: 32142917
|
 |
|
Xu Y, Li Y, Pan J, Kang X, et al. EM2D9, a monoclonal antibody against Integrin a5b1, has potent antitumor activity
on endometrial cancer in vitro and in vivo. Cancer Lett 2020 Mar 3. pii: S0304-3835(20)30082.
PMID: 32142917
|
|
|
|